Angiotensin II, human is a well-characterized regulatory octapeptide widely used in structural and receptor-binding research. Its hydrophobic-polar arrangement supports folding analysis and interaction mapping. The peptide is valuable for studying minimal binding motifs in regulatory pathways. Applications include peptide chemistry and biosynthesis modeling.
CAT No: A15009
Synonyms/Alias:ANGIOTENSIN II; 4474-91-3; Angiotensin II human; Hypertensin; Human angiotensin II; Angiotensin II (human); Ang II; 5-L-Isoleucineangiotensin II; Angiotensin II, human; 5-Isoleucine-angiotensin II; Angiotensin II (mouse); Giapreza; Asp-Arg-Val-Tyr-Ile-His-Pro-Phe; 1-8-Angiotensin I; Ile(5)-angiotensin II; Isoleucine5-angiotensin II; CHEBI:2719; Delivert; angiotensine II; ANG-(1-8)Octapeptide; isoleucine(5)-angiotensin II; UNII-M089EFU921; DRVYIHPF; Ile5-angiotensin II; Angiotensin II, 5-L-isoleucine-; 1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide; Angiotensin II (human type); CHEMBL408403; LJPC-501; Angiotensinum II; Angiotensin II acetate salt; L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine; L-Phenylalanine, N-(1-(N-(N-(N-(N-(N2-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-; N-(1-(N-(N-(N-(N-(N(2)-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine; (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid; (3S)-3-AMINO-3-{[(1S)-4-CARBAMIMIDAMIDO-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-CARBOXY-2-PHENYLETHYL]CARBAMOYL}PYRROLIDIN-1-YL]-3-(1H-IMIDAZOL-4-YL)-1-OXOPROPAN-2-YL]CARBAMOYL}-2-METHYLBUTYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}BUTYL]CARBAMOYL}PROPANOIC ACID; Alanine, N-(1-(N-(N-(N-(N-(N2-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-3-phenyl-, L-; Angiotensinum II (INN-Latin); Angiotensin cento, human; Angiotensina II (INN-Spanish); Angiotensin II, ile(5)-; Angiotensin ii [INN:JAN]; Angiotensin 2; Angiotensin-(1-8) Octapeptide; Delivert (TN); C50H71N13O12; Angiotensin II heavy; Angiotensin II (9CI); Angiotensin II (USAN); SCHEMBL1189; Angiotensin II (acetate); Ang II (acetate); DRVYIHPF (acetate); GTPL2504; SCHEMBL9013957; DTXSID4036778; SCHEMBL20502357; CHEBI:48432; C01CX09; DTXSID30196288; CHEBI:131170; ty-10721; M089EFU921; Angiotensin II (human type) (JAN); BDBM50228195; BDBM50236697; HB3488; AKOS016010178; DB11842; NCGC00167130-01; DA-70862; HY-13948; NS00074073; Asp1-Arg2-Val3-Tyr4-Ile5-His6-Pro7-Phe8; C02135; C75211; D02014; DRVY-I*-HPF [I*= I(13C6,15N)]; EN300-19742056; Q412999; 32044-01-2; 4474-91-3 (salt); ANG-(1-8)Octapeptide, Hypertensin, 4474-91-3, Giapreza; Conalbumin (328-332), 1226776-54-0, RVPSL peptide; ProteoMass(TM) Angiotensin II MALDI-MS Standard, vial of 10 nmol; (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-4-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid; (3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]carbamoyl}-2-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(diaminomethylidene)amino]butyl]carbamoyl}propanoic acid; L-phenylalanine, L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More